Paul S. Herendeen

Valeant Pharmaceuticals International

Executive Vice President and Chief Financial Officer

Overview

Paul S. Herendeen made an average of $13.5M in compensation at Valeant Pharmaceuticals International from 2016 to 2018.

Annual data

2018

In 2018, Paul S. Herendeen earned a total compensation of $6.4M as Executive Vice President and Chief Financial Officer at Valeant Pharmaceuticals International.

Ranking1,191 out of 10,945
Percentile89.1%

Paul S. Herendeen's 2018 compensation ranked 1,191st out of 10,945 executive pay records tracked by us this year.

Herendeen earned more than 89.1% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking103 out of 1,249
Percentile91.8%

In the industry group of Drugs, Herendeen's pay ranked 103rd out of 1,249 executive pay records tracked by us in 2018.

Herendeen earned more than 91.8% of executives in this group.

Non-Equity Incentive Plan$2,028,000
Option Awards$1,049,860
Salary$1,000,000
Stock Awards$2,310,572
Other$12,375
Total$6,400,807

Herendeen received $2.3M in stock awards, which accounts for 36.10% of total compensation.

Herendeen also received $2M in non-equity incentive plan, $1M in option awards, $1M in salary and $12.4K in other compensation.

Paul S. Herendeen's Pay$6,400,807
Median Employee's Pay$37,872
Pay Ratio169 : 1

For fiscal year 2018, the annual total compensation for Paul S. Herendeen was $6,400,807 and for the median employee at Valeant Pharmaceuticals International was $37,872. The resulting ratio of Paul S. Herendeen's pay to the pay of median employee was 169 to one.

2017

In 2017, Paul S. Herendeen earned a total compensation of $2.6M as Executive Vice President and Chief Financial Officer at Valeant Pharmaceuticals International.

Ranking4,042 out of 13,783
Percentile70.7%

Paul S. Herendeen's 2017 compensation ranked 4,042nd out of 13,783 executive pay records tracked by us this year.

Herendeen earned more than 70.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking303 out of 1,567
Percentile80.7%

In the industry group of Drugs, Herendeen's pay ranked 303rd out of 1,567 executive pay records tracked by us in 2017.

Herendeen earned more than 80.7% of executives in this group.

Non-Equity Incentive Plan$1,590,000
Salary$1,000,000
Other$7,950
Total$2,597,950

Herendeen received $1.6M in non-equity incentive plan, which accounts for 61.20% of total compensation.

Herendeen also received $1M in salary and $8K in other compensation.

2016

In 2016, Paul S. Herendeen earned a total compensation of $31.4M as Executive Vice President and Chief Financial Officer at Valeant Pharmaceuticals International.

Ranking40 out of 14,038
Percentile99.7%

Paul S. Herendeen's 2016 compensation ranked 40th out of 14,038 executive pay records tracked by us this year.

Herendeen earned more than 99.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking3 out of 1,500
Percentile99.8%

In the industry group of Drugs, Herendeen's pay ranked 3rd out of 1,500 executive pay records tracked by us in 2016.

Herendeen earned more than 99.8% of executives in this group.

Bonus$10,400,000
Option Awards$15,937,869
Salary$346,154
Stock Awards$4,690,500
Total$31,374,523

Herendeen received $15.9M in option awards, which accounts for 50.80% of total compensation.

Herendeen also received $10.4M in bonus, $346.2K in salary and $4.7M in stock awards.

Zoetis

Former Executive Vice President and Chief Financial Officer

Overview

Paul S. Herendeen made an average of $2.4M in compensation at Zoetis from 2014 to 2016.

Annual data

2016

In 2016, Paul S. Herendeen earned a total compensation of $2.8M as Former Executive Vice President and Chief Financial Officer at Zoetis.

Ranking3,383 out of 14,038
Percentile75.9%

Paul S. Herendeen's 2016 compensation ranked 3,383rd out of 14,038 executive pay records tracked by us this year.

Herendeen earned more than 75.9% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking250 out of 1,500
Percentile83.3%

In the industry group of Drugs, Herendeen's pay ranked 250th out of 1,500 executive pay records tracked by us in 2016.

Herendeen earned more than 83.3% of executives in this group.

Bonus$300,000
Option Awards$666,667
Salary$445,962
Stock Awards$1,333,301
Other$103,072
Total$2,849,002

Herendeen received $1.3M in stock awards, which accounts for 46.80% of total compensation.

Herendeen also received $300K in bonus, $666.7K in option awards, $446K in salary and $103.1K in other compensation.

2015

In 2015, Paul S. Herendeen earned a total compensation of $3.1M as Former Executive Vice President and Chief Financial Officer at Zoetis.

Ranking3,039 out of 13,589
Percentile77.6%

Paul S. Herendeen's 2015 compensation ranked 3,039th out of 13,589 executive pay records tracked by us this year.

Herendeen earned more than 77.6% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking306 out of 1,485
Percentile79.4%

In the industry group of Drugs, Herendeen's pay ranked 306th out of 1,485 executive pay records tracked by us in 2015.

Herendeen earned more than 79.4% of executives in this group.

Non-Equity Incentive Plan$595,350
Option Awards$599,990
Salary$630,000
Stock Awards$1,199,956
Other$82,638
Total$3,107,934

Herendeen received $1.2M in stock awards, which accounts for 38.61% of total compensation.

Herendeen also received $595.4K in non-equity incentive plan, $600K in option awards, $630K in salary and $82.6K in other compensation.

2014

In 2014, Paul S. Herendeen earned a total compensation of $1.3M as Former Executive Vice President and Chief Financial Officer at Zoetis.

Ranking6,502 out of 12,932
Percentile49.7%

Paul S. Herendeen's 2014 compensation ranked 6,502nd out of 12,932 executive pay records tracked by us this year.

Herendeen earned more than 49.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking610 out of 1,316
Percentile53.6%

In the industry group of Drugs, Herendeen's pay ranked 610th out of 1,316 executive pay records tracked by us in 2014.

Herendeen earned more than 53.6% of executives in this group.

Non-Equity Incentive Plan$167,130
Option Awards$437,495
Salary$207,614
Stock Awards$437,468
Other$18,686
Total$1,268,393

Herendeen received $437.5K in option awards, which accounts for 34.49% of total compensation.

Herendeen also received $167.1K in non-equity incentive plan, $207.6K in salary, $437.5K in stock awards and $18.7K in other compensation.